August 14-15, 2007 Washington, D.C.
The diagnostics industry is rapidly growing, and one of the strongest segments is in point-of-care diagnostics for near-patient testing or home use. Technologies are becoming available that will enable point-of-care assays that are rapid, accurate, and easy to use. The development of assays for applications in cardiac treatment, infectious disease and immune disease will be highlighted, as well as the demand for generating reliable data and reducing costs. With the prospect of pandemic influenza and emerging infectious disease outbreaks, point-of-care assays will address a serious unmet medical need.